How do I explain Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency to patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Explain G6PD Deficiency to Patients

G6PD deficiency is an inherited condition where red blood cells lack enough of a protective enzyme, making them vulnerable to breaking apart (hemolysis) when exposed to certain triggers like specific medications, infections, or foods like fava beans.

What G6PD Deficiency Is

  • G6PD is a "housekeeping" enzyme present in all cells that produces NADPH, a substance that protects cells—especially red blood cells—from oxidative damage 1
  • The deficiency arises from inherited mutations that reduce enzyme stability, causing enzyme levels to drop as red blood cells age 1
  • This is the most common inherited enzyme disorder worldwide, affecting approximately 400 million people 2
  • It follows an X-linked inheritance pattern, meaning it predominantly affects males, though females can be carriers or affected if they inherit two copies 3, 4

Who Gets It

  • The condition is most common in people of Mediterranean, African, Middle Eastern, Indian, and Southeast Asian descent 5, 6
  • In African populations, 10-15% of individuals carry the African variant (GdA-) 7
  • The Ashkenazi Jewish population has relatively higher prevalence for certain genetic conditions, though G6PD specifically varies by ethnic background 8
  • The condition has now migrated globally and should be considered a worldwide disease 2

What Happens in G6PD Deficiency

  • Most people with G6PD deficiency are completely asymptomatic under normal conditions and live normal lives 1, 4
  • Problems only occur when red blood cells face oxidative stress they cannot handle due to the enzyme deficiency 2
  • When triggered, red blood cells break apart (hemolyze), causing acute hemolytic anemia 1

When Problems Occur

Three Main Triggers:

  1. Certain medications - particularly antimalarials (primaquine), antibiotics (dapsone, sulfonamides), and other oxidant drugs 5, 6
  2. Infections - various bacterial and viral infections can trigger hemolysis 1, 2
  3. Fava beans - ingestion causes a condition called "favism" in susceptible individuals 1, 2

Two Critical Life Periods:

  • Newborn period: Severe jaundice can develop, potentially requiring phototherapy or exchange transfusion 5
  • Childhood and beyond: Acute hemolytic crises when exposed to triggers 9

Important Variant Differences

The severity depends on which genetic variant you have:

  • Mediterranean variant (Gdmed): Causes life-threatening hemolysis requiring strict avoidance of all oxidant drugs 7, 6
  • African variant (GdA-): Produces milder, self-limited hemolysis that typically stops on its own 5, 7
  • Patients with 30-70% enzyme activity and non-Mediterranean variants may tolerate some medications with close monitoring 5, 6

Medications to Absolutely Avoid

These drugs are strictly contraindicated and can cause severe, life-threatening hemolysis:

  • Primaquine (antimalarial) 7, 6
  • Dapsone (antibiotic) 5, 7
  • Rasburicase (for tumor lysis syndrome) 5, 6
  • Methylene blue (methylthioninium chloride) 5, 7, 6
  • Sulfonamide antibiotics 6

Medications That Are Safe

These medications have NOT been shown to cause hemolytic crises and can be used safely:

  • Benzodiazepines (for anxiety) 2
  • Codeine and codeine derivatives (for pain) 2
  • Propofol (anesthesia) 2
  • Fentanyl and other opioids (for pain) 2
  • Ketamine (anesthesia) 2
  • Artemisinin-based combination therapies for malaria treatment 7
  • Chloroquine/hydroxychloroquine in standard doses appear relatively safe 7

What to Watch For (Signs of Hemolysis)

If exposed to a trigger, watch for these symptoms and seek immediate medical attention:

  • Dark or tea-colored urine
  • Yellowing of skin or eyes (jaundice)
  • Extreme fatigue or weakness
  • Rapid heartbeat
  • Shortness of breath
  • Pale skin
  • Back or abdominal pain

Essential Actions for Patients

  1. Always inform every healthcare provider (doctors, dentists, pharmacists) about your G6PD deficiency before receiving any medication 2
  2. Carry a medical alert card or wear a medical alert bracelet 2
  3. Screen first-degree relatives (parents, siblings, children) for G6PD deficiency 5
  4. Avoid fava beans completely 2
  5. Seek immediate medical attention if you develop dark urine or jaundice after taking a new medication or during an infection 2

Special Considerations for Women

  • Pregnant women with G6PD deficiency can safely use chloroquine for malaria prevention, as it does not harm the fetus 7
  • However, the fetus may be G6PD-deficient even if the mother is normal, so primaquine and tafenoquine are contraindicated during pregnancy regardless of maternal G6PD status 7
  • Women who are carriers (heterozygous) may have variable enzyme levels and require quantitative testing to determine their risk 5

Testing Recommendations

  • If you have Mediterranean, African, Indian, or Southeast Asian ancestry, screening is recommended before starting any oxidant drugs 5, 6
  • For newborns with severe jaundice not responding to phototherapy, G6PD testing should be performed 5
  • Avoid testing during or immediately after a hemolytic episode, as results may be falsely normal 5

Key Takeaway

The most effective management strategy is prevention—avoid known triggers, inform all healthcare providers of your condition, and you can live a completely normal, healthy life 2

References

Research

Glucose-6-Phosphate Dehydrogenase Deficiency.

Hematology/oncology clinics of North America, 2016

Guideline

G6PD Deficiency Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

G6PD Deficiency Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications Contraindicated in G6PD Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucose-6-phosphate dehydrogenase deficiency--report of 4 cases.

Journal of Korean medical science, 1992

Related Questions

Can lactulose and prednisone be given to a G6PD (Glucose-6-phosphate dehydrogenase) deficient patient with internal hemorrhoids?
Can I be a carrier of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, given my son has it and I have hyperferritinemia?
Can benzodiazepines (benzos) trigger hemolysis in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Is cetirizine (antihistamine) safe for a child with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency?
Is co-amoxiclav (amoxicillin and clavulanic acid) safe to use in a patient with G6PD (Glucose-6-phosphate dehydrogenase) deficiency?
What is the appropriate ICD-10 (International Classification of Diseases, 10th Revision) code for a routine screening mammogram in an asymptomatic female patient?
What sleep medication is safe for patients at risk of atrial fibrillation (A. Fib)?
What is the management approach for a patient with hematuria (blood in urine) while taking cephalexin (a cephalosporin antibiotic), considering their past medical history, including any previous kidney issues, allergies, or experiences with antibiotics?
What is hepatic polycystosis (polycystic liver disease)?
What are the considerations for increasing the dose of Invega Sustenna (paliperidone) in an adult patient with a psychiatric condition, such as schizophrenia, who is currently receiving 234mg intramuscularly (IM) and is due for their next dose?
What is the treatment approach for splenic injuries based on the American Association for the Surgery of Trauma (AAST) grading system?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.